Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05169437
Title Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (PAVO)
Acronym PAVO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Tempus Labs
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST